Trinity Biotech (TRIB) Raw Materials (2016 - 2025)
Trinity Biotech's (TRIB) quarterly Raw Materials came in at $11.5 million in Q4 2025, up 14.48% year-on-year from $10.0 million in Q4 2024, and up 14.48% quarter-over-quarter from $10.0 million in Q4 2024.
Trinity Biotech (TRIB) Raw Materials (2016 - 2025) Analysis & Trends
Trinity Biotech has disclosed Raw Materials across 7 years of filings, most recently posting $11.5 million for Q4 2025.
- Raw Materials for Q4 2025 came in at $11.5 million, up 14.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.5 million (up 14.48% YoY), and the FY2025 annual result was $11.5 million, up 14.48% from the prior year.
- Raw Materials came in at $11.5 million for Q4 2025 at Trinity Biotech, up from $10.0 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $11.5 million in Q4 2025 to a low of $10.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 26,200.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.49 Mn |
| Dec 31, 2024 | 10.03 Mn |
| Dec 31, 2020 | 12.17 Mn |
| Dec 31, 2019 | 12.65 Mn |
| Dec 31, 2018 | 10.56 Mn |
| Dec 31, 2017 | 10.35 Mn |
| Dec 31, 2016 | 9.18 Mn |